Kilimanjaro Christian Medical College, Tanzania   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Moshi Tanzania, United Republic of (1997)

Organization Overview

First Clinical Trial
2004
NCT00851630
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kilimanjaro Christian Medical Centre | Kilimanjaro Christian Medical Centre,Moshi,Tanzania | Kilimanjaro Christian Medical Centre, Tanzania | Kilimanjaro Christian Medical College | Kilimanjaro Christian Medical University College | Kilimanjaro Christian Medical University College (KCMUCo), Tanzania | Kilimanjaro Clinical Research Institute and Ifakara Health Institute

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiotoxicity (Phase 2)

HIV Infections (Phase 2)

Immune Reconstitution Inflammatory Syndrome (Phase 4)

Malaria (Phase 4)

Parasitemia (Phase 2)

Tuberculosis (Phase 4)

Tuberculosis, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 20
  • # of Trial APIs: 32